Dual immune checkpoint inhibitor therapy significantly increases risk of developing Type 1 Diabetes Mellitus
Dual immune checkpoint inhibitor therapy increases risk of type 1 diabetes
This meta-analysis of 65,925 adult cancer patients found that dual immune checkpoint inhibitor therapy significantly increases the risk of I…
Cancer patients receiving dual immune checkpoint inhibitor therapy face a significantly higher risk of developing type 1 diabetes compared t…
Metabolic parameters MTV and TLG predict poorer survival in NSCLC patients on immune checkpoint inhibitors
Specific PET scan metrics predict outcomes for lung cancer patients
This systematic review and meta-analysis of 33 studies evaluated baseline [18F] FDG PET/CT metabolic parameters as prognostic indicators for…
Certain measurements from PET scans can help doctors predict how well lung cancer patients will respond to immune checkpoint inhibitor thera…
Perioperative immune checkpoint inhibitors with chemotherapy increase pathological complete response rate by 2.91 RR
Immune Checkpoint Inhibitors Combined With Chemotherapy Improve Cancer Response
This meta-analysis of randomized controlled trials evaluated perioperative immune checkpoint inhibitors combined with chemotherapy for resec…
Adding immune checkpoint inhibitors to chemotherapy may significantly improve response rates for patients with certain types of stomach and …
First-line immune checkpoint inhibitors plus anti-angiogenic therapy improve progression-free survival and response rates in advanced RCC
Combination Therapy Shows Better Outcomes for Advanced Renal Cell Carcinoma
This meta-analysis of 4,977 patients found that first-line immune checkpoint inhibitors combined with anti-angiogenic therapy significantly …
A new combination of immune checkpoint inhibitors and anti-angiogenic therapy shows better survival rates than standard treatment for advanc…
cGAS-STING pathway activation drives inflammation, fibrosis, and podocyte injury in various kidney diseases
New research identifies a key pathway in kidney disease progression
This systematic review synthesizes preclinical data on the cGAS-STING signaling pathway's role in acute kidney injury, chronic kidney diseas…
A specific signaling pathway called cGAS-STING acts as a central hub, linking inflammation and metabolism to several types of serious kidney…
Immune checkpoint inhibitors in rectal cancer: balancing anti-tumor effects against ICI-associated colorectal injury
Immune drugs for rectal cancer can cause intestinal damage
This systematic review examines immune checkpoint inhibitors (ICIs) in rectal cancer, highlighting robust anti-tumor effects in dMMR/MSI-H t…
New research explores how specific proteins in the gut help manage side effects from immune checkpoint inhibitors used to treat rectal cance…
Elevated pretreatment pan-immune-inflammation value correlates with worse survival outcomes in patients treated with immune checkpoint inhibitors
High inflammation levels may signal poorer survival for cancer patients
This systematic review and meta-analysis of 3,272 participants across 28 cohorts found that elevated pretreatment PIV is associated with sho…
A new look at cancer data suggests that high inflammation scores before treatment can predict shorter survival for those using immune checkp…
Immune checkpoint inhibitors show limited activity in unselected pancreatic ductal adenocarcinoma without specific biomarkers
New Strategies Target Immune Therapies for Pancreatic Cancer
This mini review examines the role of immune checkpoint blockade, vaccines, and cellular therapies in recurrent pancreatic ductal adenocarci…
New research highlights specific ways to better select patients for immune checkpoint inhibitors and advanced cell therapies in pancreatic c…
Neoadjuvant immune checkpoint inhibitors plus chemotherapy increase pathological complete response in early-stage triple-negative breast cancer
Immune checkpoint inhibitors improve response in triple-negative breast cancer
This meta-analysis of 3,377 patients found that neoadjuvant immune checkpoint inhibitors combined with chemotherapy significantly increased …
Adding immune checkpoint inhibitors to chemotherapy helps more patients with early-stage triple-negative breast cancer achieve a complete re…
First-line immune checkpoint inhibitor combinations improve overall survival in extensive-stage small-cell lung cancer
Immune checkpoint inhibitors combined with chemotherapy improve small cell lung cancer survival
This meta-analysis of 3,910 patients with extensive-stage small-cell lung cancer (ES-SCLC) found that first-line immune checkpoint inhibitor…
Combining immune checkpoint inhibitors with chemotherapy shows better survival rates for patients with extensive stage small cell lung cance…
Natural polysaccharides combined with immune checkpoint inhibitors show synergistic benefits in preclinical and early clinical observations
Natural sugars may help patients whose cancer resists immune drugs
This systematic review examines the use of natural polysaccharides as immune adjuvants for patients with solid tumors resistant to immune ch…
New research explores how natural polysaccharides can help boost the effectiveness of immunotherapy for patients with advanced solid tumors.
Chemokine networks regulate triple-negative breast cancer tumor microenvironment but clinical translation remains limited
Chemokine Targets Show Promise in Lab but Face Clinical Hurdles
This systematic review examines the role of chemokine networks and targeted interventions in the triple-negative breast cancer immune microe…
New research highlights the role of chemokine networks in breast cancer, showing strong results in labs despite challenges in current clinic…